Adam Christopher Martin, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 7373 Perkins Rd, Baton Rouge, LA 70808 Phone: 225-769-4044 |
Robert Lucas Patin, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 7777 Hennessy Blvd, Suite 4000, Baton Rouge, LA 70808 Phone: 225-766-7441 Fax: 225-769-6343 |
Dr. Phuong Thanh Dinh, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 2515 O' Neal Lane, Suite 5, Baton Rouge, LA 70816 Phone: 225-752-2419 Fax: 225-752-2420 |
Dr. Erica Durlacher, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 257 Lee Dr Ste Q, Baton Rouge, LA 70808 Phone: 225-819-0120 Fax: 225-293-1285 |
Dr. Diana Marie Lebreton, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 5151 Plank Rd, Suite 15, Baton Rouge, LA 70805 Phone: 225-356-3489 Fax: 225-355-6103 |
Bichngoc Pham, OD Optometrist Medicare: Medicare Enrolled Practice Location: 550 Connell Park Ln, Baton Rouge, LA 70806 Phone: 225-924-2020 Fax: 225-924-2809 |
Dr. Stephaine L Cauley, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 9001 Summa Ave, Baton Rouge, LA 70809 Phone: 225-761-5200 Fax: 225-761-5618 |
Dr. Elmo Clyde Dean Jr., O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 4747 Oneal Ln, Ste. A, Baton Rouge, LA 70817 Phone: 225-755-0988 Fax: 225-755-3235 |
Mitresh Optometry Llc Optometrist Medicare: Medicare Enrolled Practice Location: 7673 Perkins Rd Ste B-3, Baton Rouge, LA 70810 Phone: 225-757-0505 |
Stephen M Welcker, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 400 Russell Ave Bldg 41, Belle Chasse, LA 70037 Phone: 504-678-7970 |
Belle Chasse Optical Optometrist Medicare: Medicare Enrolled Practice Location: 102 Woodland Hwy, Ste 10, Belle Chasse, LA 70037 Phone: 504-393-0002 Fax: 504-392-0770 |
Thuy Thanh Nguyen, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 102 Woodland Hwy Ste 10, Belle Chasse, LA 70037 Phone: 504-393-0002 Fax: 504-392-0770 |
Dr. Michael Wade Jorgensen Od Llc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 187 Burt Blvd, Ste A, Benton, LA 71006 Phone: 318-935-5080 Fax: 318-935-5085 |
Dr. Michael Wade Jorgensen, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 187 Burt Blvd, Ste A, Benton, LA 71006 Phone: 318-935-5080 Fax: 318-935-5085 |
Marc Hautot, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 409 Avenue F, Bogalusa, LA 70427 Phone: 985-735-8137 Fax: 985-732-4777 |
Dr. Stephen Eugene Warren Ix, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 305 Alabama Ave, Bogalusa, LA 70427 Phone: 985-732-5181 |
Can, Inc. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 413 Austin St, Bogalusa, LA 70427 Phone: 985-732-4900 |
Charles Savage Adams, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1911 Benton Rd, Ste C, Bossier City, LA 71111 Phone: 318-742-4012 Fax: 318-742-1692 |
Dr. Kelvin Lamark Garner, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 5914 Summerville Ln, Bossier City, LA 71111 Phone: 318-773-2100 |
Adams Eyecare Optometrist Medicare: Medicare Enrolled Practice Location: 1911 Benton Rd, Suite C, Bossier City, LA 71111 Phone: 318-742-4012 Fax: 318-742-1692 |
News Archive
A diet higher in plant-derived compounds known as phytoestrogens is linked with a lower lung cancer risk, according to a study in the current issue of Journal of the American Medical Association (JAMA).
The role of sex in human disease is a growing area of research. Although estrogen (in females) and androgens (in males) are often seen as possible causes for such differences, sex chromosomes, including the male-specific Y chromosome, may also play a role. However, it has been difficult to understand how the Y chromosome could contribute to disease in men, in part because it is much more difficult to sequence than all other chromosomes.
Human Genome Sciences, Inc. today announced interim results through Week 12 following the end of treatment in a Phase 2b clinical trial conducted by Novartis to evaluate the safety and efficacy of ZALBIN™ (albinterferon alfa-2b), an investigational agent, administered monthly in combination with ribavirin in 391 treatment-naive patients with genotypes 2 and 3 chronic hepatitis C virus. The primary efficacy endpoint is sustained virologic response (SVR) at Week 48 (24 weeks following the end of treatment).
New research in the April issue of Anesthesiology shows for the first time a genetic marker in patients who have a greater likelihood of surviving sepsis.
BusinessWeek: "In chasing revenue to help pay for health-care reform, Democrats have managed to rally two groups that tend to oppose each other—unions and Big Business. The focus of their ire: a proposed 40% excise tax on high-premium or so-called Cadillac health plans."
› Verified 9 days ago